Medpace Holdings (MEDP) EPS (Diluted) Growth (1y) (2016 - 2026)
Medpace Holdings (MEDP) EPS (Diluted) Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 10.71% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 59.30% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 17.55% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 58.79% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -6.55% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -21.08% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -9.61% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 18.37% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 13.90% |
| 10 | Medpace Holdings | 16.56 Bn | 16.06 Bn | 201.64 Mn | 37.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.23% |
| Mar 31, 2026 | 16.43% |
| Dec 31, 2025 | 25.21% |
| Sep 30, 2025 | 28.34% |
| Jun 30, 2025 | 12.48% |
| Mar 31, 2025 | 14.58% |
| Dec 31, 2024 | 48.64% |
| Sep 30, 2024 | 35.29% |
| Jun 30, 2024 | 42.37% |
| Mar 31, 2024 | 41.42% |
| Dec 31, 2023 | 20.57% |
| Sep 30, 2023 | 8.50% |
| Jun 30, 2023 | 32.03% |
| Mar 31, 2023 | 34.45% |
| Dec 31, 2022 | 53.66% |
| Sep 30, 2022 | 58.12% |
| Jun 30, 2022 | 38.35% |
| Mar 31, 2022 | 46.97% |
| Dec 31, 2021 | -1.61% |
| Sep 30, 2021 | 17.92% |